The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation. - Test2 - elhamkhani - TriplyDB

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

http://www.wikidata.org/entity/Q37622571

about

Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities Is there a new dawn for selective mineralocorticoid receptor antagonism?RhoA Ambivalently Controls Prominent Myofibroblast Characteritics by Involving Distinct Signaling Routes Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy.Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling.Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?Atrial fibrillation: mechanisms, therapeutics, and future directions.Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.A systemic Pasteurella multocida toxin aggravates cardiac hypertrophy and fibrosis in mice.MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure.Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension.Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats.Genomic and rapid effects of aldosterone: what we know and do not know thus far.Eplerenone inhibits atrial fibrosis in mutant TGF-β1 transgenic mice.Association of Mineralocorticoid Receptor Polymorphism I180V With Left Ventricular Hypertrophy in Resistant Hypertension.Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology Effects of hypoestrogenism and/or hyperaldosteronism on myocardial remodeling in female mice

P2860

Q26825697-B62B1C36-1885-45FE-BFC7-A3E88108CEF5 Q27027792-218ABC22-8BD1-4280-A303-B3B86B1DBD99 Q27318689-F9C7664F-9904-4C99-8A9F-F051D638176B Q33645941-D68EE2FD-9CF3-4E14-AAA0-923FE5725803 Q36315623-45A32459-4C0D-4DAC-B98B-99EE6F173265 Q36437145-9657536E-D6C3-49F8-83CD-CF13CE4364A7 Q37590158-66D6B41F-D768-4E7F-8001-A396FEAC4098 Q39164366-4F79A3F0-B579-4C9F-9F25-D1BA31CDCC2A Q39199991-BBEA2C57-B280-4C62-BA6F-D96CA0ADC0B4 Q41249294-8782DEB3-3B5F-4836-887D-609C9475149B Q42330259-97F821D0-5CBB-46BC-B05D-5A063B1A5001 Q47318642-7E4F8600-6AB5-49F6-9DC7-33BEC4B8B421 Q48356668-8A32F9B7-19FC-41C6-97D2-FF2189F97C42 Q50756676-6A3286F1-D6D6-4C7D-A717-E21DF5C51220 Q51273122-8D8EE8AF-90FF-4AD7-B927-0FE4A1A93B84 Q51688046-428D59FF-935F-4BB5-B64F-726A782DD0E2 Q53476197-F29A4921-0DB7-4AED-9D3B-F178C23D438D Q57493008-29F87A25-35C6-4D2F-8CE8-6C4A3173845D Q59126955-44821786-C2C1-4097-B725-F46B9C017DFC

P2860

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

http://www.wikidata.org/entity/Q37622571

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

@en

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

@nl

type

label

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

@en

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

@nl

prefLabel

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

@en

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

@nl

P1433

Q37622571-787D6A3F-552B-47DA-BFE2-A2FCCE011F44

P1476

Q37622571-ECA35072-5CE8-4941-A085-EB6C0CFBE8A1

P2093

Q37622571-288640FE-DB55-4570-AA8F-9CBEE29EA574

Q37622571-33C71FE3-2DE1-4634-BC42-30FBEDE29AC1

Q37622571-5E35AC1C-697A-4DDF-8935-644AF4695DC8

Q37622571-824A8039-6574-4ADD-B023-837BF3FBFCBF

Q37622571-94D48DC7-9DE4-4DD9-8871-22145C373449

Q37622571-A55C611E-9F36-4353-801F-6C3F19FB74DC

Q37622571-BCF98A0C-21F4-400E-B262-064CF972858C

P2860

Q37622571-093984F7-8DC8-4271-81D0-0B14AD8505EB

Q37622571-10A5F657-20FB-4A7C-9906-3E1848395D4C

Q37622571-1F8951D8-DF9B-4EEC-B1D0-4377AE07F788

Q37622571-259D835B-14A6-4CA7-8BD0-91200580B351

Q37622571-25B9C574-E05C-4471-B9D7-5A08A8B3A963

Q37622571-2815C085-CE72-4A53-A10B-60D04F55ECEC

Q37622571-2914151B-5FF1-4AC7-A53A-E20E665F43EA

Q37622571-2CE2866C-A03B-4B6C-A5D8-A77E8D576A6B

Q37622571-38AFBBAB-B35B-45F7-AF1F-7C08DD012859

Q37622571-434755AA-427D-4E35-8981-C8DE0E486B32

P304

Q37622571-F16EFA69-8441-494D-A270-2C4402CB023F

P31

Q37622571-B9018294-79B0-42C5-ABB7-BECE283AC672

P356

Q37622571-A3AB073F-1E50-45BE-8937-0A7E1027E5B8

P407

Q37622571-A48EBDF4-34F9-460F-BFBF-BB41F781994B

P433

Q37622571-4CCEF0EA-495D-40FE-8A92-6C28CD2A0F16

P478

Q37622571-2A3E8854-1622-41DD-AC70-2E538044D8A8

P50

Q37622571-C9B539D4-3BB8-430F-815E-11AAD8477685

P577

Q37622571-A80BA483-08BB-4607-B3C7-DEF2A80F7CA8

P698

Q37622571-E1716011-B4DA-4B9D-A6C5-86DDD65A42D6

P921

Q37622571-FCBB79B7-5CD3-41DA-A63D-89F0F29300C1

P932

Q37622571-77DEA12F-AC80-49F7-A34C-7A4121E524CF

P356

JBC.M113.519256

P1433

Journal of Biological Chemistry

P1476

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

@en

P2093

Christian Selzer

http://www.w3.org/2001/XMLSchema#string

Hans-Joachim Schäfers

http://www.w3.org/2001/XMLSchema#string

Matthias Lenski

http://www.w3.org/2001/XMLSchema#string

Michael Böhm

http://www.w3.org/2001/XMLSchema#string

Oliver Adam

http://www.w3.org/2001/XMLSchema#string

Pia Schuster

http://www.w3.org/2001/XMLSchema#string

Ulrich Laufs

http://www.w3.org/2001/XMLSchema#string

P2860

A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule.

MicroRNAs: genomics, biogenesis, mechanism, and function

Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1

Role of miR-21 in the pathogenesis of atrial fibrosis

Specificity and mechanism of action of some commonly used protein kinase inhibitors

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

Chronic intermittent hypoxia induces 11beta-hydroxysteroid dehydrogenase in rat heart

Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC)

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

P304

6656-6668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M113.519256

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

289

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24469458

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

3945327

http://www.w3.org/2001/XMLSchema#string